Key result
Tumor thrombus growing against the direction of venous return (GADVR) was an independent risk factor for progression-free survival in patients with renal cell carcinoma, reducing median survival to 14.0 months compared to 32.0 months in non-GADVR patients.
Why the study?
The impact of tumor thrombus growing against the direction of venous return on surgical approach, surgical complexity, and prognosis was not well understood.
Does the presence of tumor thrombus growing against the direction of venous return (GADVR) worsen progression-free survival and increase surgical complexity in patients with renal cell carcinoma and venous tumor thrombus?
Cohort (n=213)
No
Does the presence of tumor thrombus growing against the direction of venous return (GADVR) worsen progression-free survival and increase surgical complexity in patients with renal cell carcinoma and venous tumor thrombus?
In patients with renal cell carcinoma and venous tumor thrombus, tumor thrombus growing against the direction of venous return is associated with higher surgical complexity and is an independent risk factor for worse progression-free survival.
Answers are grounded in this paper and cite their sources.
GADVR may aid risk stratification in RCC with venous thrombus; hypothesis-generating and requires validation before guiding care.
Purpose: To explore the effect of tumor thrombus growing against the direction of venous return (GADVR) tumor thrombus on the choice of surgical approach, the impact on the complexity of the surgery and the prognosis.Methods: We retrospectively analyzed the clinicopathological data of 213 patients, who underwent surgery in a single center of Peking University Third Hospital between January 2016 and June 2020. For right renal cell carcinoma (RCC) and venous tumor thrombus (VTT), imaging revealed a filling defect in the left renal vein, which was significantly enhanced in enhanced imaging, suggesting that the tumor thrombus grew against the direction of venous return into the left renal vein. For left RCC and VTT, at least one of the left renal vein branches has tumor thrombus. The branches include the left adrenal vein, the left gonadal vein (testicular vein or ovarian vein), and the left ascending lumbar vein. The patients were divided into two groups according to whether they were GADVR tumor thrombus, and we compare the clinicopathological characteristics of GADVR tumor thrombus and non-GADVR tumor thrombus. Univariate and multivariate Cox regression analyses were performed to explore the risk factors that affect the prognosis of patients with RCC and VTT. Kaplan-Meier plots were conducted to evaluate the effect of GADVR on progression-free survival (PFS).Results: Compared with non-GADVR tumor thrombus, patients with GADVR tumor thrombus had a higher proportion of open surgery (76.2% vs. 52.1%, P=0.035), a higher proportion of tumor thrombus adhering to the inferior vena cava (IVC) vessel wall (81% vs. 45.8%, P=0.002), a higher proportion of segmental resection of the IVC vessel wall (61.9% vs. 15.6%, P<0.001); higher preoperative serum creatinine value (110.0μmol/ L vs. 91.0μmol/L, P=0.015), a higher proportion of tumor thrombus combined with bland thrombus (non-tumor thrombus) (57.1% vs. 19.8%, P<0.001). In terms of surgical complexity, patients with GADVR tumor thrombus had a longer median operation time (379.0 min vs. 308 min, P=0.038), more median surgical blood loss (1400ml vs. 600ml, P=0.018), and more postoperative complications (52.4% vs. 30.7%, P=0.045). Multivariate Cox regression analysis showed that GADVR tumor thrombus, symptoms, postoperative serum creatinine, distant metastasis, sarcomatoid feature, pathological type, lymph node dissection were independent risk factors for PFS. Patients with GADVR tumor thrombus's median survival time was 14.0 months, while patients with non-GADVR tumor thrombus were 32.0 months (P = 0.016). GADVR tumor thrombus is an independent risk factor for PFS in patients with RCC and VTT.Conclusion: GADVR tumor thrombus is a characteristic feature of tumor thrombus, with an incidence of 9.9%. It has a higher proportion of open surgery and higher surgical complexity, which is an independent risk factor for PFS.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) conducted a cohort in Renal cell carcinoma with venous tumor thrombus (n=213). Tumor thrombus growing against the direction of venous return (GADVR) vs. Non-GADVR tumor thrombus was evaluated on Progression-free survival (PFS) (HR 2.039, 95% CI 1.030-4.038, p=0.041). Tumor thrombus growing against the direction of venous return (GADVR) was an independent risk factor for progression-free survival in patients with renal cell carcinoma, reducing median survival to 14.0 months compared to 32.0 months in non-GADVR patients.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: